CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2022
Back to search
Official data from USPTO
CELGENE COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELGENE COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
ST13
US500000077561055Class
42
Filing
77561055
Registration
3726390
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/09/2022
Trademark type
Word
Nice classes
42
Filing date
09/03/2008
Registration date
12/15/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/08/2019
Last transaction
12/09/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/04/2009
First use in commerce
02/04/2009
Drawing code
4
Owner type
03
Owner location
Summit, NJ
Examiner
CORWIN, CHARLOTTE
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing servicespharmacogenetic testspredictive medical testspersonalized medical testsgene sequencing-based tests and genotyping base on the assessmentdevelopment and application of genomic discoveries in the pharmaceuticalinformatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assaysDNA sequencing protocolsimmunoassay and methods for drug discovery; scientific researchdevelopment of pharmaceuticals or diagnostic methods for others; agrochemical product development for others
Publications
History of USPTO decisions and trademark events.
35 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/08/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/08/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/08/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
12/17/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/15/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/06/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/06/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/06/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/28/2015
E815
TEAS SECTION 8 & 15 RECEIVED
07/10/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
12/15/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
11/10/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/09/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/20/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/20/2009
IUAF
USE AMENDMENT FILED
10/02/2009
EISU
TEAS STATEMENT OF USE RECEIVED
10/02/2009
EX1G
SOU EXTENSION 1 GRANTED
08/24/2009
EXT1
SOU EXTENSION 1 FILED
08/24/2009
EEXT
SOU TEAS EXTENSION RECEIVED
08/24/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/31/2009
PUBO
PUBLISHED FOR OPPOSITION
01/06/2009
NPUB
NOTICE OF PUBLICATION
12/17/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/02/2008
ALIE
ASSIGNED TO LIE
12/01/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/25/2008
DOCK
ASSIGNED TO EXAMINER
11/20/2008
NWAP
NEW APPLICATION ENTERED
09/08/2008
Continuous trademark protection
Get notified about every new filing that threatens CELGENE COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.